Literature DB >> 6807683

Noradrenaline release and clearance in relation to age and blood pressure in man.

P C Rubin, P J Scott, K McLean, J L Reid.   

Abstract

Plasma noradrenaline concentration increases with age. This study was designed to investigate whether an increased rate of noradrenaline release into the circulation or a decrease in clearance is primarily responsible for this age related change in concentration. Sixteen healthy male subjects were studied, eight young (21-36 years) and eight old (65-78 years). Clearance was calculated from steady state noradrenaline concentrations during constant rate infusions of unlabelled noradrenaline. Clearance did not differ between the two groups: young 4.8 l/min (range 2.7-6.1), old 4.1 (range 2.6-8.2). The old subjects had significantly greater rates of release. Supine: young 10.3 nmol/min (range 5.3-17.6), old 19.7 (range 10.1-30), P less than 0.05. Standing: young 17.2 (range 11-36.4), old 29.2 (range 21.8-47.9), P less than 0.01. No significant relationship was found in either supine or standing position between rate of noradrenaline release and either systolic or diastolic blood pressure. These results indicate that plasma noradrenaline concentration rises with age because of an increased rate of release, but that this increased release is not responsible for the higher blood pressure seen in the elderly.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6807683     DOI: 10.1111/j.1365-2362.1982.tb00948.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  9 in total

Review 1.  The cardiovascular system.

Authors:  A Moore; A A Mangoni; D Lyons; S H D Jackson
Journal:  Br J Clin Pharmacol       Date:  2003-09       Impact factor: 4.335

Review 2.  Cardiovascular drug therapy in elderly patients: specific age-related pharmacokinetic, pharmacodynamic and therapeutic considerations.

Authors:  Arduino A Mangoni
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

3.  A double-blind and cross-over comparison of once daily doxazosin and placebo with steady-state pharmacokinetics in elderly hypertensive patients.

Authors:  P J Scott; J Hosie; M G Scott
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

Review 4.  Human ageing and the sympathoadrenal system.

Authors:  D R Seals; M D Esler
Journal:  J Physiol       Date:  2000-11-01       Impact factor: 5.182

Review 5.  Physiological changes due to age. Implications for cardiovascular drug therapy.

Authors:  I Stolarek; P J Scott; F I Caird
Journal:  Drugs Aging       Date:  1991 Nov-Dec       Impact factor: 3.923

Review 6.  Autonomic Cardiovascular Damage during Post-menopause: the Role of Physical Training.

Authors:  Hugo C D Souza; Geisa C S V Tezini
Journal:  Aging Dis       Date:  2013-09-20       Impact factor: 6.745

Review 7.  Diabetic neuropathy in elderly patients. What can be done?

Authors:  J Belmin; P Valensi
Journal:  Drugs Aging       Date:  1996-06       Impact factor: 3.923

Review 8.  Heart Rate Variability and Cardiovascular Fitness: What We Know so Far.

Authors:  Hugo Celso Dutra Souza; Stella Vieira Philbois; Ana Catarine Veiga; Bruno Augusto Aguilar
Journal:  Vasc Health Risk Manag       Date:  2021-11-13

Review 9.  A brief review of chronic exercise intervention to prevent autonomic nervous system changes during the aging process.

Authors:  Rogério Brandão Wichi; Kátia De Angelis; Lia Jones; Maria Claudia Irigoyen
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.